Back to funds

Darwin Global Management, Ltd.

Updated 6 days ago

Managed by Darwin Global Management, Ltd. • Latest filing Q3 2026

Portfolio value
$4B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$4.9B
Q1 2026$3.8B
Q2 2026$3.8B
Q3 2026$4B

Top holdings

5 positions as of Q3 2026

View filing
R

REVOLUTION MEDICINES INC

Value
$2.2B
Shares
10.63M
% Port
54.66%
G

GENMAB A/S

Value
$638.6M
Shares
17.90M
% Port
16.00%
B

BELITE BIO INC

Value
$526M
Shares
3.10M
% Port
13.18%
A

ABIVAX SA

Value
$398.2M
Shares
4.02M
% Port
9.98%
R

ROIVANT SCIENCES LTD

Value
$246.7M
Shares
6.75M
% Port
6.18%

Explore